Skip to main content
Fresenius SE & Co. KGaA logo

Fresenius SE & Co. KGaA — Investor Relations & Filings

Ticker · FRE ISIN · DE0005785604 LEI · XDFJ0CYCOO1FXRFTQS51 F Human health and social work activities
Open in API
Filings indexed 1,398 across all filing types
Latest filing 2010-03-13 Regulatory Filings
Country DE Germany
Listing F FRE

About Fresenius SE & Co. KGaA

https://www.fresenius.com/

Fresenius SE & Co. KGaA is a global healthcare company that provides system-critical products and services for leading therapies for the care of critically and chronically ill patients. The company's portfolio encompasses a wide range of products and services for dialysis, hospitals, and outpatient medical care. Key offerings include intravenously administered generic drugs, biopharmaceuticals, biosimilars, clinical nutrition, and infusion therapies. Additionally, the company operates a large network of private hospitals and outpatient centers. Through its strategic investment in Fresenius Medical Care, it is a leading global provider of products and services for individuals with renal diseases.

Recent filings

Filing Released Lang Actions
Company Statutes of Fresenius SE, March 2010
Regulatory Filings Classification · 99% confidence The document text consists of the 'Statutes of Fresenius SE' as of March 12, 2010. It details the company's name, registered office, corporate purpose, notification procedures, and extensive provisions regarding its subscribed capital, authorized capital (Genehmigtes Kapital I & II), and conditional capital (Bedingtes Kapital I, II, & III) related to stock options and convertible bonds. This content is foundational corporate governance and structural documentation, not a periodic financial report (like 10-K or IR), an earnings announcement (ER), or a proxy statement (DEF 14A/PSI). It most closely aligns with documents detailing internal rules, board structure, and governance practices, which fits the definition of Governance Information (CGR). Since the document is the actual statutes, it is not an announcement of a report (RPA).
2010-03-13 English
Entsprechenserklärung 2010
Governance Information Classification · 98% confidence The document is titled "Erklärung des Vorstands und des Aufsichtsrats der Fresenius SE zu den Empfehlungen der 'Regierungskommission Deutscher Corporate Governance Kodex' in der Fassung vom 18. Juni 2009 gemäß § 161 AktG". This explicitly states it is a declaration regarding the German Corporate Governance Code (DCGK). This type of declaration, detailing compliance or deviations from governance recommendations, falls directly under the definition of Governance Information (CGR). It is not an Annual Report (10-K), an Audit Report (AR), or a general Earnings Release (ER). The document is a formal statement on internal rules and board structure practices.
2010-03-12 German
Declaration of Conformity 2010
Governance Information Classification · 98% confidence The document is titled "Declaration by the Management Board and Supervisory Board of Fresenius SE on the recommendations of the 'Government Commission on the German Corporate Governance Code' pursuant to Section 161 of the German Stock Corporation Act (AktG)". This declaration explicitly addresses compliance (or non-compliance) with corporate governance code recommendations, which is a core component of corporate governance reporting. This aligns directly with the definition of Governance Information (CGR), which covers internal rules, board structure, and governance practices, rather than a general Audit Report (AR) or a specific remuneration report (DEF 14A). The document is a formal declaration of governance adherence.
2010-03-12 English
Fresenius SE: Release according to Article 26a, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a short announcement (1264 characters) dated February 26, 2010, titled 'Total Voting Rights announcement according to Article 26a of the WpHG'. It explicitly states the total number of voting rights as of the end of February 2010. This content directly relates to shareholder voting rights and is not a full report, a management change, or a dividend notice. It fits best under 'Declaration of Voting Results & Voting Rights Announcements' (DVA), as it declares the total voting rights count, which is a key component of voting structure disclosure.
2010-02-26 English
Fresenius SE: Record financial results in 2009 All financial targets met or exceeded Positive outlook for 2010
Earnings Release Classification · 100% confidence The document is titled 'Fresenius SE: Record financial results in 2009' and provides key financial metrics for the full year 2009 (sales, operating income, net income, EPS) along with a positive outlook for 2010. It is explicitly labeled as an 'Ad hoc announcement' disseminated via DGAP, which typically precedes or accompanies a formal earnings release or interim/annual report filing. Since it contains the primary financial highlights and results summary for a period, it fits the definition of an Earnings Release (ER). It is too detailed for just a Report Publication Announcement (RPA) but is not the comprehensive Annual Report (10-K) or a full Interim Report (IR) as it focuses on the final annual results summary in an ad-hoc format. Document Length Check: The document length is 3939 characters, which is short, but the content is a summary of final annual results, not just an announcement that a report is attached. Therefore, ER is the most appropriate classification over RPA. FY 2009
2010-02-24 English
Analyst Meeting - 2009 Results
Investor Presentation Classification · 95% confidence The document is titled "Analyst Meeting – 2009 Results" and dated February 24, 2010. It contains detailed financial performance summaries for the fiscal year 2009 across various business segments (Fresenius Kabi, Helios, Vamed, Biotech), including sales, EBIT, dividend proposals, and guidance achievement summaries. This content structure—a presentation summarizing past annual results and providing outlook—is characteristic of an Investor Presentation (IP) or materials related to an Annual General Meeting (AGM-R). Since it is a presentation format summarizing full-year results and strategy updates, Investor Presentation (IP) is the most fitting category, as it is more detailed than a simple Earnings Release (ER) but not the formal 10-K filing itself. It is clearly a presentation intended for investors/analysts.
2010-02-24 English

Browse filings by year

31 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.